Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT-EHA CAR-T 2019 | CAR-T treatment journey and the role of the nurse

Rose Ellard • 15 Feb 2019
EBMT-EHA CAR-T 2019
General CAR-T Cyclophosphamide Fludarabine

Rose Ellard, MSc, of King’s College Hospital NHS Foundation Trust, London, UK, gives an overview of the treatment journey of a patient receiving CAR T-cell therapy, from referral to monitoring after treatment. Ms Ellard highlights the role of nurses throughout this journey.

More from Rose Ellard

1:27
Becoming CAR-T educated
Rose Ellard • 27 Sep 2019
1:26
EBMT guidelines CAR-T education & guidelines for nurses
Rose Ellard • 2 Aug 2019
1:34
CAR-T: symptoms and their assessment
Rose Ellard • 15 Feb 2019
0:35
The importance of patient monitoring post-CAR-T treatment
Rose Ellard • 15 Feb 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals